• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR SMOOTH SALINE IMPLANTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR SMOOTH SALINE IMPLANTS Back to Search Results
Lot Number 6425763
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Headache (1880); Anxiety (2328); Sleep Dysfunction (2517); Confusion/ Disorientation (2553)
Date of Event 06/01/2015
Type of Reportable Event Serious Injury
Event or Problem Description
In 2011 at the age of (b)(6) i had a breast augmentation using mentor 3500cc smooth saline implants.Over the next 6 years i began to experience various symptoms such as daily headaches, insomnia, anxiety, and brain fog that i just wrote off at the time.By the summer of 2015 my health had took a turn for the worse.I became bedridden and only made attempts to get up to see another doctor to just get no answers to my sudden health decline that felt like i was dying some days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMOOTH SALINE IMPLANTS
Common Device Name
SMOOTH SALINE IMPLANTS
Manufacturer (Section D)
MENTOR
MDR Report Key6456465
Report NumberMW5068879
Device Sequence Number17201951
Product Code FWM
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2016
Reporter Type Voluntary
Type of Report Initial
Report Date (Section B) 03/31/2017
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Lot Number6425763
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/31/2017
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ADDERALL; D3; EPSOM SALT SOAKS; MAGNESIUM; OTC MEDS: NIACIN; PROBIOTIC; RX MEDS: EFFEXOR; VALIUM
Outcome Attributed to Adverse Event Hospitalization;
Patient Age26 YR
Patient Weight61
-
-